New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry ...

We're also trying to make sure we look back at some of the trades that are still alive so we can keep you posted. We wrote ...

Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap ...

Shares of certain biotech firms were rising ahead of market open on Monday on news of the departure of the FDA’s vaccine chief, Dr. Vinay Prasad. Prasad, the head of the FDA’s division of vaccines and ...

In this article, we will look at the 12 Cheap Biotech Stocks to Buy Now.

This stock could make you a fortune in the next two years, or lose you a whole lot of money.

The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is rising at a staggering ...

Biotech investors have rarely united so strongly against a Food and Drug Administration official as they did against Vinay Prasad, who led the FDA's vaccines and related biological products division a ...

CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 17, Morgan Stanley increased its price target on CRISPR Therapeutics AG ...

Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 20, Bank of America Securities lowered the price target on ...

The stock looks like a great pick to help turn investors into multimillionaires, given enough time. Everyone should save ...

Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to spotlight some Biotech names in his "Best Stocks in the Market." ...